Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 13;27(24):8860.
doi: 10.3390/molecules27248860.

The Synergistic Mechanism of Total Saponins and Flavonoids in Notoginseng-Safflower against Myocardial Infarction Using a Comprehensive Metabolomics Strategy

Affiliations

The Synergistic Mechanism of Total Saponins and Flavonoids in Notoginseng-Safflower against Myocardial Infarction Using a Comprehensive Metabolomics Strategy

Meng Fang et al. Molecules. .

Abstract

Notoginseng and safflower are commonly used traditional Chinese medicines for benefiting qi and activating blood circulation. A previous study by our group showed that the compatibility of the effective components of total saponins of notoginseng (NS) and total flavonoids of safflower (SF), named NS-SF, had a preventive effect on isoproterenol (ISO)-induced myocardial infarction (MI) in rats. However, the therapeutic effect on MI and the synergistic mechanism of NS-SF are still unclear. Therefore, integrated metabolomics, combined with immunohistochemistry and other pharmacological methods, was used to systematically research the therapeutic effect of NS-SF on MI rats and the synergistic mechanism of NS and SF. Compared to NS and SF, the results demonstrated that NS-SF exhibited a significantly better role in ameliorating myocardial damage, apoptosis, easing oxidative stress and anti-inflammation. NS-SF showed a more significant regulatory effect on metabolites involved in sphingolipid metabolism, glycine, serine, and threonine metabolism, primary bile acid biosynthesis, aminoacyl-tRNA biosynthesis, and tricarboxylic acid cycle, such as sphingosine, lysophosphatidylcholine (18:0), lysophosphatidylethanolamine (22:5/0:0), chenodeoxycholic acid, L-valine, glycine, and succinate, than NS or SF alone, indicating that NS and SF produced a synergistic effect on the treatment of MI. This study will provide a theoretical basis for the clinical development of NS-SF.

Keywords: metabolomics; myocardial infarction; notoginseng; safflower; synergistic.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Evaluation of the heart functions of rats in every group. (A) The M-mode echocardiograms for rats in different groups. (B) The parameters of ECG-M for rats in different groups (mean ± SD, n = 6). ## p < 0.01, when versus sham group; * p < 0.05, ** p < 0.01, when versus model group. Normal: normal group; Sham: sham-operated group; Model: model group; Positive group: positive control group; NS: total saponins of notoginseng group; SF: total flavonoids of safflower group; NS–SF: the compatibility of NS and SF group.
Figure 2
Figure 2
Effects of NS, SF and NS–SF on myocardial fibrosis and apoptosis induced by MI in rat heart tissues. (A) H&E staining of left ventricular (LV) tissue showed pathological and morphological changes in different groups (magnification, ×400). The necrotic myocardium is labeled with a black arrow, and inflammatory cells are labeled with a yellow arrow. (B) The results of TUNEL staining in different groups. Arrows indicate apoptotic cardiomyocyte nuclei. (C) Apoptosis rate of myocardial cells in each group (mean ± SD, n = 6). (D) The serum levels of MI-associated biochemical markers of rats in different groups (mean ± SD, n = 6). ## p < 0.01, when versus sham group; * p < 0.05, ** p < 0.01, when versus model group. Normal: normal group; Sham: sham-operated group; Model: model group; Positive group: positive control group; NS: total saponins of notoginseng group; SF: total flavonoids of safflower group; NS–SF: the compatibility of NS and SF group.
Figure 3
Figure 3
Effects of NS, SF and NS–SF on plasma anti-inflammatory and antioxidant activities of MI-induced cardiac hypertrophy in rats (mean ± SD, n = 6), (A) MDA, (B) SOD, (C) GSH-Px, (D) TNF-α, (E) IL-6, and (F) IL-1α. ## p < 0.01, when versus sham group; p < 0.05, * p < 0.01, when versus model group. Normal: normal group; Sham: sham-operated group; Model: model group; Positive group: positive control group; NS: total saponins of notoginseng group; SF: total flavonoids of safflower group; NS–SF: the compatibility of NS and SF group.
Figure 4
Figure 4
The PCA score plot of rats in different groups. (A) Positive mode by UPLC−QTOF/MS. (B) Negative mode by UPLC−QTOF/MS (C) 1H NMR. Normal: normal group; Sham: sham−operated group; Model: model group; Positive group: positive control group; NS: total saponins of notoginseng group; SF: total flavonoids of safflower group; NS–SF: the compatibility of NS and SF group.
Figure 5
Figure 5
The OPLS-DA of the plasma samples from sham and model rats. (A) Positive mode by UPLC-QTOF/MS. (B) A combination plot of S-plot and VIP values in positive mode. (C) Negative mode by UPLC-QTOF/MS. (D) A combination plot of S-plot and VIP values in negative mode. (E) 1H NMR. (F) A combination plot of S-plot (green squares) and VIP (blue squares) values in 1H NMR. Sham: sham-operated group; Model: model group.
Figure 6
Figure 6
Schematic representation of the effects of NS, SF, and NS–SF on the metabolic network of the vital MI-altered metabolites. Sham: sham-operated group; Model: model group; Positive group: positive control group; NS: total saponins of notoginseng group; SF: total flavonoids of safflower group; NS–SF: the compatibility of NS and SF group.

Similar articles

Cited by

References

    1. Saleh M., Ambrose J.A. Understanding myocardial infarction. F1000Research. 2018;7:1378. doi: 10.12688/f1000research.15096.1. - DOI - PMC - PubMed
    1. Wong Z.W., Thanikachalam P.V., Ramamurthy S. Molecular understanding of the protective role of natural products on isoproterenol-induced myocardial infarction: A review. Biomed. Pharmacother. 2017;94:1145–1166. doi: 10.1016/j.biopha.2017.08.009. - DOI - PubMed
    1. Smit M., Coetzee A.R., Lochner A. The pathophysiology of myocardial ischemia and perioperative myocardial infarction. J. Cardiothorac. Vasc. Anesth. 2020;34:2501–2512. doi: 10.1053/j.jvca.2019.10.005. - DOI - PubMed
    1. Femia G., French J.K., Juergens C., Leung D., Lo S. Right ventricular myocardial infarction: Pathophysiology, clinical implications and management. Rev. Cardiovasc. Med. 2021;22:1229–1240. doi: 10.31083/j.rcm2204131. - DOI - PubMed
    1. Layne K., Ferro A. Traditional Chinese medicines in the management of cardiovascular diseases: A comprehensive systematic review. Br. J. Clin. Pharmacol. 2017;83:20–32. doi: 10.1111/bcp.13013. - DOI - PMC - PubMed